204 related articles for article (PubMed ID: 1482479)
1. Impact of multidrug therapy on the treatment and control of leprosy.
Chatterjee BR
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):271-2. PubMed ID: 1482479
[No Abstract] [Full Text] [Related]
2. Acute renal failure and multidrug therapy for leprosy.
Nishioka Sde A
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):259-60. PubMed ID: 9251601
[No Abstract] [Full Text] [Related]
3. Multidrug therapy--the pathway for global leprosy elimination.
al-Qubati Y; al-Kubati AS
Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in the chemotherapy of leprosy.
McDougall AC
Lepr Rev; 1997 Dec; 68(4):294-8. PubMed ID: 9503864
[No Abstract] [Full Text] [Related]
5. Leprosy control through multidrug therapy (MDT).
Noordeen SK
Bull World Health Organ; 1991; 69(3):263-9. PubMed ID: 1893503
[TBL] [Abstract][Full Text] [Related]
6. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
Pai VV; Bulchand HO; Revankar CR; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
[No Abstract] [Full Text] [Related]
7. The need for new drugs in the treatment and control of leprosy.
Baker RJ
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):78-97. PubMed ID: 2181046
[No Abstract] [Full Text] [Related]
8. [Leprosy control and multidrug therapy in Togo: problems and perspectives].
Edorh AA; Tignokpa N; David MT; Ihou E
Acta Leprol; 1992; 8(1):23-8. PubMed ID: 1523962
[TBL] [Abstract][Full Text] [Related]
9. Rationale for the preventive treatment of leprosy.
Lechat MF
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S63-6. PubMed ID: 10700940
[No Abstract] [Full Text] [Related]
10. Implementation of multidrug therapy for leprosy control programmes.
Porichha D
Lepr Rev; 1990 Dec; 61(4):392-3. PubMed ID: 2280664
[No Abstract] [Full Text] [Related]
11. Paucibacillary multidrug therapy in leprosy--7.5 years experience.
Reddy BN
Indian J Lepr; 1992; 64(4):546-7. PubMed ID: 1308534
[No Abstract] [Full Text] [Related]
12. Multidrug therapy in leprosy. WHO Study Group.
Nurs J India; 1984 Apr; 75(4):83-6, 90. PubMed ID: 6565263
[No Abstract] [Full Text] [Related]
13. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010).
World Health Organization
Indian J Lepr; 2006; 78(1):7-31. PubMed ID: 16646281
[No Abstract] [Full Text] [Related]
14. Progress in leprosy elimination.
World Health Forum; 1998; 19(2):212-3. PubMed ID: 9652225
[No Abstract] [Full Text] [Related]
15. Risk of relapse in leprosy after fixed-duration multidrug therapy.
Li HY; Hu LF; Huang WB; Liu GC; Yuan LC; Jin Z; Li X; Li JL; Yang ZM
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597
[TBL] [Abstract][Full Text] [Related]
16. The final push to eliminate leprosy.
Neira MP
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S7-9. PubMed ID: 11757179
[No Abstract] [Full Text] [Related]
17. Multidrug therapy in paucibacillary leprosy.
Jopling WH
Lepr Rev; 1990 Dec; 61(4):391. PubMed ID: 2280662
[No Abstract] [Full Text] [Related]
18. Multidrug therapy in the control of leprosy. A field study.
Becx-Bleumink M
Trop Geogr Med; 1994; 46(2):109-14. PubMed ID: 8079385
[No Abstract] [Full Text] [Related]
19. Multi-drug therapy in leprosy: an effective method of control.
Indian J Lepr; 1984; 56(1):102-12. PubMed ID: 6548238
[TBL] [Abstract][Full Text] [Related]
20. Eliminating leprosy as a public health problem--is the optimism justified?
Noordeen SK; Roxas MG; Fine PE; Smith WC; Feenstra P; Gokhale SD; Joo LK; Huan-Ying L; Khalafalla G; Becx-Bleumink M; Srinivasan H; Rao CK; Lechat MF; Sansarricq H
World Health Forum; 1996; 17(2):109-44. PubMed ID: 8936264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
